Greater Hamburg Area
Senior business leader with 20+ years of experience in MedTech and IVD, currently leading a €100M+ portfolio across 40+ EMEA markets with full P&L responsibility. Proven track record in transforming businesses and outperforming market growth, including scaling a €20M business to €60M and achieving #1 market position (25% share) in a low-growth environment. Experienced in driving commercial growth, launching new diagnostic platforms, and aligning clinical value, market access, and strategy to accelerate adoption and deliver sustainable impact.
Lead a €100M+ diagnostics portfolio across 40+ EMEA markets, with full P&L ownership Built and scaled a matrix organization (8 → 15 FTEs, 3 team leaders) Manage €2M marketing budget, optimizing investment toward growth and innovation Launched and scaled new platforms (POC & Immunochemistry), expanding into high-growth segments Developed market access and health economic strategies, demonstrating 20–30% reduction in antibiotic use Built and activated 50+ stakeholder network, driving adoption and market penetration
Transformed business from €20M → €60M (3x growth) Achieved #1 position with 25% market share Outperformed ~2% CAGR market Led the urinalysis business across EMEA, defining strategic direction, portfolio development, and regional execution. Expanded the role of urinalysis from core laboratory testing toward broader clinical decision support, strengthening relevance in urology, microbiology, and bladder cancer pathways. Worked across commercial and clinical stakeholder groups to build adoption strategies and pathway-oriented value communication.
Led product management and application support activities for the urinalysis portfolio across EMEA. Strengthened customer engagement, product performance, and cross-functional execution.
Held full P&L responsibility for the Diabetes Care & POCT division, leading marketing, sales, and business development. Led entry into a €60M diabetes diagnostics market, achieving 40% market share in Year 1 and 60% in Year 2. Improved gross margin from 40% to 55% through focused portfolio management, commercial execution, and pricing discipline. Built and executed the full business and marketing strategy for market entry and scale-up.
Managed a global IVD product portfolio of suppliers from Europe, the USA, and China. Delivered 30% year-on-year growth through portfolio development and commercial execution. Expanded market presence into 150+ hospitals and laboratories. Generated 20% export growth across the Balkans and Cyprus.
- Operated as engineer and technical advisor for both medical and security equipment, working principally on medical imaging equipment and high-tech security systems - Developed and delivered medical and security equipment training presentations, including providing security systems training to police officers for the 2004 Athens Olympic Games - Supported customer service management initiatives through provision of comprehensive client technical advice and support
- Serving within the biomedical technology department, training in the servicing, repair and quality and quantity control of equipment. - Trained in the biomedical technology management, competition evaluation, bid evaluation and the organization of intensive care units and surgeries